1. Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patients
    Shuai Liu et al, 2022, Endocrine Journal CrossRef
  2. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities
    Prasanna Srinivasan Ramalingam et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  3. HMGB1’in Kanser ve Tedavisiyle İlişkisi
    Eylem TAŞKIN GÜVEN et al, 2019, Düzce Üniversitesi Bilim ve Teknoloji Dergisi CrossRef
  4. Research Progress of High-Mobility Group Box Protein B1 in Respiratory Diseases
    润玉 邵, 2021, Advances in Clinical Medicine CrossRef
  5. miR‑142‑3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1
    Hui Dong et al, 2021, Experimental and Therapeutic Medicine CrossRef
  6. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
    A K M Nawshad Hossian et al, 2021, Scientific Reports CrossRef
  7. Sufentanil Suppresses Cell Carcinogenesis Via Targeting miR-186-5p/HMGB1 Axis and Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer
    Di Liu et al, 2024, Molecular Biotechnology CrossRef
  8. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
    Yanhua Zuo et al, 2023, Pathology and Oncology Research CrossRef

  9. LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1


    Ruo-Tian Wang et al, 2020, OncoTargets and Therapy CrossRef
  10. Proteomic profiling and identification of significant markers from high-grade osteosarcoma after cryotherapy and irradiation
    Rashmi Madda et al, 2020, Scientific Reports CrossRef
  11. HMGB1 Promotes Lymphangiogenesis through the Activation of RAGE on M2 Macrophages in Laryngeal Squamous Cell Carcinoma
    Caili Su et al, 2022, Disease Markers CrossRef
  12. HMGB1: a double-edged sword and therapeutic target in the female reproductive system
    Yu Ren et al, 2023, Frontiers in Immunology CrossRef